Profil
Pascal Puchois is the founder of Trans-Hit Biomarkers, Inc. He previously worked as a Principal at CelMed BioSciences, Inc. and as VP-Corporate & Business Development at Chronogen, Inc. from 2009 to 2010.
Aktive Positionen von Pascal Puchois
| Unternehmen | Position | Beginn |
|---|---|---|
Trans-Hit Biomarkers, Inc.
 Trans-Hit Biomarkers, Inc. BiotechnologyHealth Technology Trans-Hit Biomarkers, Inc. is the worldwide biospecimen access CRO with the most extensive collection capability for biospecimens and clinical samples. The firm facilitates direct interactions between our customers and academic biobanks allowing the scientific and medical expertise of academics to be drawn upon and leveraged. It provide continuous support throughout the process from your initial request to the moment you receive the samples in your lab and beyond. The company is headquartered in Laval, Canada. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Pascal Puchois
| Unternehmen | Position | Ende |
|---|---|---|
Chronogen, Inc.
 Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Chronogen, Inc. develops drugs to treat age-dependent diseases. It manufactures drugs for neurodegenerative, cardiovascular, ischemia and reperfusion injury, and dyslipidemia diseases. The company was founded by Siegfried Hekimi in April 1998 and is headquartered in Montréal, Canada | Corporate Officer/Principal | 23.04.2010 |
CelMed BioSciences, Inc.
 CelMed BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Celmed BioSciences Inc. is a biopharmaceutical company. The company is engaged in developing breakthrough products to treat cancer. The company offers rational drug design and pharmacogenomic concepts to improve cancer patient care. Products of the company include Theralux and NB1011 which offers “Trojan horse solution' to treat cancer. The company is headquartered in Saint-Laurent, Canada. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
CelMed BioSciences, Inc.
CelMed BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Celmed BioSciences Inc. is a biopharmaceutical company. The company is engaged in developing breakthrough products to treat cancer. The company offers rational drug design and pharmacogenomic concepts to improve cancer patient care. Products of the company include Theralux and NB1011 which offers “Trojan horse solution' to treat cancer. The company is headquartered in Saint-Laurent, Canada. | Health Technology |
Chronogen, Inc.
Chronogen, Inc. Pharmaceuticals: MajorHealth Technology Chronogen, Inc. develops drugs to treat age-dependent diseases. It manufactures drugs for neurodegenerative, cardiovascular, ischemia and reperfusion injury, and dyslipidemia diseases. The company was founded by Siegfried Hekimi in April 1998 and is headquartered in Montréal, Canada | Health Technology |
Trans-Hit Biomarkers, Inc.
Trans-Hit Biomarkers, Inc. BiotechnologyHealth Technology Trans-Hit Biomarkers, Inc. is the worldwide biospecimen access CRO with the most extensive collection capability for biospecimens and clinical samples. The firm facilitates direct interactions between our customers and academic biobanks allowing the scientific and medical expertise of academics to be drawn upon and leveraged. It provide continuous support throughout the process from your initial request to the moment you receive the samples in your lab and beyond. The company is headquartered in Laval, Canada. | Health Technology |
